⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL199040 | 1.00 | — | — | |
| SCHEMBL331728 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1903656 | 0.97 | OR51E2 (0.38) | — | |
| SCHEMBL14890159 | 0.80 | CHRNB2 (0.32) | — | |
| SCHEMBL28428696 | 0.79 | — | — | |
| SCHEMBL21621641 | 0.79 | CHRNB2 (0.36) | — | |
| SCHEMBL6562047 | 0.79 | CHRNB2 (0.36) | — | |
| SCHEMBL6135566 | 0.78 | — | — | |
| SCHEMBL25875074 | 0.78 | — | — | |
| SCHEMBL291712 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160244484-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2016-08-25 | — | — | US | claimed |
| EP-3049428-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | Dr. August Wolff GmbH & Co. KG Arzneimittel (DE) | 2016-08-03 | — | — | EP | claimed |
| WO-2015040235-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2015-03-26 | — | — | WO | claimed |
| US-20110076307-A1 | POLYCATIONIC GENE CARRIERS FORMED OF ENDOGENOUS AMINO GROUP-BEARING MONOMERS | BIOPHARM SOLUTIONS, INC. | 2011-03-31 | — | — | US | claimed |
| WO-2009100645-A1 | POLYCATIONIC GENE CARRIERS FORMED OF ENDOGENOUS AMINO GROUP-BEARING MONOMERS | JIN TUO (CN) | 2009-08-20 | — | — | WO | claimed |
| JP-4001130-A | — | — | None | — | — | JP | disclosed |
| JP-4074106-A | — | — | None | — | — | JP | disclosed |
| EP-4684030-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-12427472-B2 | Process for removal of acid gases from a fluid stream | BASF SE (DE) | 2025-09-30 | — | — | US | disclosed |
| EP-4566608-A2 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | Gilead Sciences, Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250179102-A1 | THERAPEUTICS COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2025-06-05 | — | — | US | disclosed |
| EP-4440702-B1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES INC (US) | 2025-05-21 | — | — | EP | disclosed |
| JP-H0474106-A | PREVENTIVE FOR SENESCENCE OF SKIN AND SKIN COSMETIC CONTAINING SAME PREVENTIVE | KANEBO LTD | 1992-03-09 | — | — | JP | disclosed |
| JP-H041130-A | REMEDY FOR DISEASE ACCOMPANYING ABNORMAL ACCUMULATION OF COLLAGEN | KANEBO LTD | 1992-01-06 | — | — | JP | disclosed |
| EP-0333154-A2 | Process for the preparation of cephem derivatives and intermediates therefor | Eisai Co., Ltd. (JP) | 1989-09-20 | — | — | EP | disclosed |
| EP-0094412-B1 | MEDICAL PROCESS AND PREPARATION | JOHNSTON, Frederick Bertram (US) | 1987-07-22 | — | — | EP | disclosed |
| EP-0094412-A4 | MEDICAL PROCESS AND PREPARATION. | JOHNSTON FREDERICK BERTRAM | 1984-04-24 | — | — | EP | disclosed |
| EP-0094412-A1 | MEDICAL PROCESS AND PREPARATION. | JOHNSTON FREDERICK BERTRAM | 1983-11-23 | — | — | EP | disclosed |
| WO-1983001725-A1 | MEDICAL PROCESS AND PREPARATION | JOHNSTON, FREDERICK, BERTRAM | 1983-05-26 | — | — | WO | disclosed |
| US-4362745-A | Medical process and preparation | JOHNSTON FREDERICK B | 1982-12-07 | — | — | US | disclosed |